Dow Jones

40,781.24

1.42%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

CGEN

Compugen (CGEN)

Compugen Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/10/2009	06:00	Business Wire	Compugen Presents DAC Blockers Platform and Initial Product Candidates at Fifth Peptide Engineering Meeting in Barcelona, Spain	NASDAQ:CGEN	Compugen Ltd
20/10/2009	06:00	Business Wire	Compugen Ltd. to Review Third Quarter 2009 Results on Tuesday, October 27, 2009	NASDAQ:CGEN	Compugen Ltd
13/10/2009	06:02	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	NASDAQ:CGEN	Compugen Ltd
13/10/2009	06:00	Business Wire	Compugen and Bayer Schering Pharma to Collaborate on Compugen Discovered Oncology Target and Splice Variants	NASDAQ:CGEN	Compugen Ltd
11/08/2009	11:51	Edgar (US Regulatory)	Securities Registration (foreign private issuer) (F-3/A)	NASDAQ:CGEN	Compugen Ltd
11/08/2009	07:38	Edgar (US Regulatory)	Securities Registration (foreign private issuer) (F-3)	NASDAQ:CGEN	Compugen Ltd
28/07/2009	06:00	Business Wire	Compugen Reports Second Quarter 2009 Results	NASDAQ:CGEN	Compugen Ltd
21/07/2009	06:00	Business Wire	Compugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Retinopathy	NASDAQ:CGEN	Compugen Ltd
20/07/2009	06:00	Business Wire	Compugen Ltd. to Review Second Quarter 2009 Financial Results on Tuesday, July 28, 2009	NASDAQ:CGEN	Compugen Ltd
20/07/2009	05:05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:CGEN	Compugen Ltd
30/06/2009	05:00	Business Wire	Compugen Reports Sale of a Portion of Its Evogene Holdings	NASDAQ:CGEN	Compugen Ltd
24/06/2009	08:00	Marketwired	Stocks to Watch for Wednesday, June 24, 2009: ARYC -- Arrayit Corporation to Enter Molecular Diagnostics Using VIP(TM) Technolog	NASDAQ:CGEN	Compugen Ltd
24/06/2009	06:00	Business Wire	Compugen Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic Candidates	NASDAQ:CGEN	Compugen Ltd
23/06/2009	06:00	Business Wire	Compugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Inflammatory Bowel Disease	NASDAQ:CGEN	Compugen Ltd
17/06/2009	06:00	Business Wire	Compugen Transfers to The NASDAQ Capital Market	NASDAQ:CGEN	Compugen Ltd
02/06/2009	07:00	Business Wire	Compugen Receives Deficiency Letter from NASDAQ With Respect to Stockholders Equity	NASDAQ:CGEN	Compugen Ltd
02/06/2009	05:00	Business Wire	Compugen Appoints Dr. Anat Cohen-Dayag and Martin Gerstel as Co-CEOs	NASDAQ:CGEN	Compugen Ltd
14/05/2009	06:00	Business Wire	Compugen Announces In Vivo Confirmation of Cardiovascular Therapeutic Potential for Two Novel Peptides	NASDAQ:CGEN	Compugen Ltd
12/05/2009	06:00	Business Wire	Compugen Reports First Quarter 2009 Financial Results	NASDAQ:CGEN	Compugen Ltd
05/05/2009	02:11	Business Wire	Compugen Ltd. to Review First Quarter 2009 Financial Results on Tuesday, May 12, 2009	NASDAQ:CGEN	Compugen Ltd
29/04/2009	06:00	Business Wire	Compugen Predictive Discovery Capabilities Presented by CTO at Bio-IT Conference and Expo 2009	NASDAQ:CGEN	Compugen Ltd
01/04/2009	06:00	Business Wire	Compugen Announces Inhibition of Angiogenesis by Novel Peptide	NASDAQ:CGEN	Compugen Ltd
24/03/2009	06:00	Business Wire	Teva to Utilize Compugen-Discovered Biomarkers for Pre-Clinical Detection of Drug-Induced Kidney Toxicity	NASDAQ:CGEN	Compugen Ltd
18/03/2009	11:01	Edgar (US Regulatory)	Annual and Transition Report (foreign private issuer) (20-F)	NASDAQ:CGEN	Compugen Ltd
17/03/2009	06:00	Business Wire	Compugen Announces Positive Therapeutic Effects of Relaxin Receptor Peptide Ligand in Pulmonary Fibrosis Animal Model	NASDAQ:CGEN	Compugen Ltd
10/03/2009	05:04	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:CGEN	Compugen Ltd
13/02/2009	06:12	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CGEN	Compugen Ltd
11/02/2009	06:00	Business Wire	Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results	NASDAQ:CGEN	Compugen Ltd
09/02/2009	06:00	Business Wire	Compugen Appoints Dov Hershberg Chairman of the Board	NASDAQ:CGEN	Compugen Ltd
04/02/2009	06:00	Business Wire	Compugen Ltd. to Review Fourth Quarter and Year-End 2008 Financial Results on Wednesday, February 11, 2009	NASDAQ:CGEN	Compugen Ltd